Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "innate immune system components" refers to the collective elements that make up the body's innate (nonspecific) immune defense, which is the first line of immune response present from birth[4][5][6]. These include *physical barriers* (such as skin and mucosa), *cellular components* (including neutrophils, macrophages, dendritic cells, natural killer cells, basal cells, eosinophils, and mast cells), *soluble molecules* (like the complement system, cytokines, and chemokines), and *chemical barriers* (including lysozyme and antimicrobial peptides)[2][4][6]. These components rapidly recognize and respond to pathogens using pattern recognition receptors rather than specific antigen recognition. While essential for fighting infections and activating the adaptive immune response, "innate immune system components" is not a single molecule or defined druggable target, but a functional grouping encompassing multiple mechanisms and entities[2][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Innate immune system components.